131 related articles for article (PubMed ID: 1892572)
1. Cell proliferation in serial biopsies through human malignant brain tumours: measurement using Ki67 antibody labelling.
Parkins CS; Darling JL; Gill SS; Revesz T; Thomas DG
Br J Neurosurg; 1991; 5(3):289-98. PubMed ID: 1892572
[TBL] [Abstract][Full Text] [Related]
2. Nucleolar organizer region score and Ki-67 labelling index in high-grade gliomas and metastatic brain tumours.
Hara A; Hirayama H; Sakai N; Yamada H; Tanaka T; Mori H
Acta Neurochir (Wien); 1991; 109(1-2):37-41. PubMed ID: 1648862
[TBL] [Abstract][Full Text] [Related]
3. The monoclonal antibody Ki-67 as a marker for proliferating cells in stereotactic biopsies of brain tumours.
Ostertag CB; Volk B; Shibata T; Burger P; Kleihues P
Acta Neurochir (Wien); 1987; 89(3-4):117-21. PubMed ID: 3324650
[TBL] [Abstract][Full Text] [Related]
4. Replicative Mcm2 protein as a novel proliferation marker in oligodendrogliomas and its relationship to Ki67 labelling index, histological grade and prognosis.
Wharton SB; Chan KK; Anderson JR; Stoeber K; Williams GH
Neuropathol Appl Neurobiol; 2001 Aug; 27(4):305-13. PubMed ID: 11532161
[TBL] [Abstract][Full Text] [Related]
5. Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67.
Zuber P; Hamou MF; de Tribolet N
Neurosurgery; 1988 Feb; 22(2):364-8. PubMed ID: 2832782
[TBL] [Abstract][Full Text] [Related]
6. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas.
Onda K; Davis RL; Shibuya M; Wilson CB; Hoshino T
Cancer; 1994 Oct; 74(7):1921-6. PubMed ID: 7521787
[TBL] [Abstract][Full Text] [Related]
7. Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67.
Deckert M; Reifenberger G; Wechsler W
J Cancer Res Clin Oncol; 1989; 115(2):179-88. PubMed ID: 2715168
[TBL] [Abstract][Full Text] [Related]
8. Proliferating cell nuclear antigen (PCNA) and Ki-67 immunopositivity in human astrocytic tumours.
Kordek R; Biernat W; Alwasiak J; Liberski PP
Acta Neurochir (Wien); 1996; 138(5):509-12; discussion 513. PubMed ID: 8800324
[TBL] [Abstract][Full Text] [Related]
9. Cell proliferation in breast tumours: analysis of histological parameters Ki67 and PCNA expression.
Sullivan RP; Mortimer G; Muircheartaigh IO
Ir J Med Sci; 1993 Sep; 162(9):343-7. PubMed ID: 7903289
[TBL] [Abstract][Full Text] [Related]
10. Proliferation in human bladder carcinoma measured by Ki-67 antibody labelling: its potential clinical importance.
Bush C; Price P; Norton J; Parkins CS; Bailey MJ; Boyd J; Jones CR; A'Hern RP; Horwich A
Br J Cancer; 1991 Aug; 64(2):357-60. PubMed ID: 1892764
[TBL] [Abstract][Full Text] [Related]
11. Cell proliferation patterns in the diagnosis of astrocytomas, anaplastic astrocytomas and glioblastoma multiforme: a Ki-67 study.
Raghavan R; Steart PV; Weller RO
Neuropathol Appl Neurobiol; 1990 Apr; 16(2):123-33. PubMed ID: 2161084
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours.
Jaros E; Perry RH; Adam L; Kelly PJ; Crawford PJ; Kalbag RM; Mendelow AD; Sengupta RP; Pearson AD
Br J Cancer; 1992 Aug; 66(2):373-85. PubMed ID: 1503912
[TBL] [Abstract][Full Text] [Related]
13. p16INK4a and p19INK4d mRNA expression in neuroglial tumours: correlation with Ki67 proliferation index.
Bouvier-Labit C; Civatte M; Bartoli C; Renaud W; Pellissier JF; Figarella-Branger D
Neuropathol Appl Neurobiol; 1999 Oct; 25(5):408-16. PubMed ID: 10564531
[TBL] [Abstract][Full Text] [Related]
14. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.
Kleinschmidt-DeMasters BK; Hashizumi TL; Sze CI; Lillehei KO; Shroyer AL; Shroyer KR
J Clin Pathol; 1998 Apr; 51(4):284-93. PubMed ID: 9659240
[TBL] [Abstract][Full Text] [Related]
15. The proliferation rate of intracranial tumors as defined by the monoclonal antibody KI 67. Application of the method to paraffin embedded specimens.
Böker DK; Stark HJ
Neurosurg Rev; 1988; 11(3-4):267-72. PubMed ID: 2855108
[TBL] [Abstract][Full Text] [Related]
16. Proliferating cell nuclear antigen immunostaining and survival in cerebral astrocytoma.
Theunissen PH; Blaauw G
Histopathology; 1993 Jul; 23(1):75-9. PubMed ID: 8103499
[TBL] [Abstract][Full Text] [Related]
17. Proliferative activity assessed by anti-PCNA and Ki67 monoclonal antibodies in canine testicular tumours.
Sarli G; Benazzi C; Preziosi R; Marcato PS
J Comp Pathol; 1994 May; 110(4):357-68. PubMed ID: 7914524
[TBL] [Abstract][Full Text] [Related]
18. Proliferative potential of malignant glioma cells before and after interstitial brachytherapy.
Kunishio K; Matsumoto K; Higashi H; Adachi H; Tamiya T; Furuta T; Ohmoto T
Neurol Med Chir (Tokyo); 1999 May; 39(5):341-9. PubMed ID: 10481436
[TBL] [Abstract][Full Text] [Related]
19. The relationship between Ki-67 labeling and mitotic index in gliomas and meningiomas: demonstration of the variability of the intermitotic cycle time.
Schröder R; Bien K; Kott R; Meyers I; Vössing R
Acta Neuropathol; 1991; 82(5):389-94. PubMed ID: 1767633
[TBL] [Abstract][Full Text] [Related]
20. Ultrarapid Ki-67 immunostaining in frozen section interpretation of gliomas.
Haapasalo J; Mennander A; Helen P; Haapasalo H; Isola J
J Clin Pathol; 2005 Mar; 58(3):263-8. PubMed ID: 15735157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
